PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
250.64%
Some net income increase while 1113.HK is negative at -40.55%. John Neff would see a short-term edge over the struggling competitor.
-23.30%
Both reduce yoy D&A, with 1113.HK at -100.00%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-963.72%
Negative yoy working capital usage while 1113.HK is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
24.61%
Inventory growth of 24.61% while 1113.HK is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
No Data
No Data available this quarter, please select a different quarter.
-1099.00%
Negative yoy usage while 1113.HK is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
14.73%
Lower 'other non-cash' growth vs. 1113.HK's 162.65%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-1.48%
Negative yoy CFO while 1113.HK is 603.06%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-27.12%
Negative yoy CapEx while 1113.HK is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-100.00%
Negative yoy acquisition while 1113.HK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
100.00%
Purchases well above 1113.HK's 100.00%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-100.00%
We reduce yoy sales while 1113.HK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
42.34%
Less 'other investing' outflow yoy vs. 1113.HK's 100.00%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-231.73%
We reduce yoy invests while 1113.HK stands at 100.00%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
754.15%
Issuance growth of 754.15% while 1113.HK is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.